GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Forward Dividend Yield %

Egyptian International Pharmaceutical Investments (CAI:PHAR) Forward Dividend Yield % : 5.70% (As of May. 08, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Forward Dividend Yield %?

As of today (2024-05-08), the Forward Annual Dividend Yield of Egyptian International Pharmaceutical Investments is 5.70%.

As of today (2024-05-08), the Trailing Annual Dividend Yield of Egyptian International Pharmaceutical Investments is 5.70%.

CAI:PHAR's Forward Dividend Yield % is ranked better than
92.73% of 495 companies
in the Drug Manufacturers industry
Industry Median: 1.81 vs CAI:PHAR: 5.70

Egyptian International Pharmaceutical Investments's Dividends per Share for the three months ended in Dec. 2023 was E£0.00.

During the past 12 months, Egyptian International Pharmaceutical Investments's average Dividends Per Share Growth Rate was -33.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -21.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -11.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 1.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Egyptian International Pharmaceutical Investments was 44.30% per year. The lowest was -21.10% per year. And the median was 6.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Egyptian International Pharmaceutical Investments's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egyptian International Pharmaceutical Investments's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's Forward Dividend Yield % falls into.



Egyptian International Pharmaceutical Investments Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Egyptian International Pharmaceutical Investments Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EGP 2.0000002024-04-282024-04-290000-00-00Cash DividendannuallyEGP:EGP 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Egyptian International Pharmaceutical Investments's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=/35.10
=0.00 %

Current Share Price is E£35.10.
Egyptian International Pharmaceutical Investments's Dividends per Share for the forward twelve months is calculated as * = .

Egyptian International Pharmaceutical Investments's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=2/35.10
=5.70 %

Current Share Price is E£35.10.
Egyptian International Pharmaceutical Investments's Dividends per Share for the trailing twelve months (TTM) ended in Today is E£2.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Egyptian International Pharmaceutical Investments  (CAI:PHAR) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Egyptian International Pharmaceutical Investments Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Headlines